Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Search Results

0 results for "Syenza News Team"

No articles contain "Syenza News Team"

There are related articles below.

Related articles

These do not contain "Syenza News Team" in full, but matched part of it.

Foundayo oral GLP-1 tablet

Clinical Practice

Foundayo Oral GLP-1 Tablet Gets Positive EU Opinion

The EMA’s CHMP has backed Foundayo, a once-daily orforglipron tablet, for weight management and type 2 diabetes.

By João L. CarapinhaRead →
confirmatory platform trials

Clinical Practice Free account

EMA Draft Reflection Paper Sets Rules for Confirmatory Platform Trials

“EMA’s draft reflection paper sets out how confirmatory platform trials should handle controls, randomisation, blinding and multiplicity. Comments are due 31 January 2027. #SyenzaNews #MarketAccess #ClinicalTrials”

By João L. CarapinhaRead →
reinforcement learning rTMS

Clinical Practice

Reinforcement learning rTMS for depression treatment

Reinforcement learning rTMS for depression: a new npj Digital Medicine study tests protocol recommendations against clinician choices in 1,609 adults.

By João L. CarapinhaRead →
AI operating room scheduling

Clinical Guidelines And Protocols

AI operating room scheduling: LLM agent teams reach feasible plans

How can AI-powered scheduling transform operating room efficiency and deliver major cost savings?

Recent advancements are enabling hospitals to optimize resource allocation, reduce cancellations, and streamline workflows through intelligent automation.

Discover how this technology is reshaping surgical operations and improving financial outcomes.
#SyenzaNews #AIinHealthcare #HealthcareInnovation #ai #DigitalTransformation

By João L. CarapinhaRead →
most favored nation drug pricing

Drug Pricing

Most favored nation drug pricing: why US patient groups push back

The National Health Council says importing foreign price controls through most favored nation pricing will not serve American patients.

By João L. CarapinhaRead →
FDA rare disease framework

Clinical Guidelines And Protocols Free account

FDA Rare Disease Framework Initiative Would Tailor Review to Small Populations

What steps is the FDA taking to accelerate rare disease treatments?

The FDA’s new Rare Disease Framework Initiative aims to streamline regulatory pathways, enhance collaboration with sponsors, and improve patient access to innovative therapies.

Explore how this could reshape drug development for underserved patient populations.

#SyenzaNews #regulatoryaffairs #drugdevelopment #innovation #healthcarepolicy

By João L. CarapinhaRead →